Autoimmune Retinopathy Panel by Immunoblot (ARP)
Use
The Autoimmune Retinopathy Panel (ARP) by immunoblot is used for the detection of autoimmune retinopathy, a condition that affects vision due to immune system-mediated damage to the retina. The test identifies specific autoantibodies that are often associated with retinal dysfunction or degeneration, helping in the diagnosis and management of patients with suspected immune-related retinopathies.
Special Instructions
It is essential to submit a completed OHSU Ocular request form, clinical history, and referring physician information along with the specimen. Without this information, the testing cannot proceed.
Limitations
The test is specifically designed to detect antibodies associated with autoimmune retinopathy and may not detect all possible antibodies linked to the condition. Results should be interpreted in the context of clinical findings and other diagnostic procedures. Cross-reactivity with non-specific antibodies or other autoimmune diseases may lead to false-positive results.
New York Approved
Methodology
Immunoassay (Immunoblot)
Biomarkers
Result Turnaround Time
16-35 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
5 mL
Minimum Volume
3 mL
Container
Plastic vial
Collection Instructions
Draw blood in a plain, red-top tube(s), serum gel tube(s) is acceptable. Spin down and send serum refrigerated.
Causes for Rejection
Hemolysis: Mild reject; Gross reject. Thawing: Warm reject; Cold OK.
Stability Requirements
| Temperature | Period |
|---|---|
| Refrigerated | 7 days |